Active B12 Test Market 2019 | Regional Analysis, Global Market Player, Business growth, Upcoming trends 2023

-

Vitamin B12 plays an important role to keep our body stay healthy. Our body is not capable to produce vitamin B12, thus, we have to get it from animal-based foods or supplements. As our body does not store vitamin B12, so we need to intake these animal-based foods or supplements regularly. Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a key role in the functioning of the brain and nervous system and the formation of red blood cells. Rising prevalence of vitamin deficiency disease and neurological disorders increase the market of active B12 test globally. According United States Department of Agriculture Agricultural Research Service, the prevalence of vitamin deficiency is found to be high in America. Additionally, according to report published by Alzheimer's Disease International (ADI), in 2015, the prevalence of occurring dementia is more in middle-income countries in comparison to a developed nation.



Companies are showing much interest in the market of active B12 Test, as they feel there are huge opportunities and gaps between the market demand and supply of active B12 Test market. Thus, companies are showing more interest in research and development activities for introducing the best procedure that meets the requirement of the market. The development has been made by Axis-Shield Diagnostics Ltd. In Sep 2014, will develop the Active-B12 test for Siemens Healthcare allowing more laboratories worldwide to perform the test.

Get free sample @ https://www.marketresearchfuture.com/sample_request/4199

Global Key Players
  • Axis-Shield Diagnostics Ltd. (U.S.),
  • Abbott (U.S.),
  • Siemens Healthcare Private Limited (U.S.),
  • DiaSorin S.p.A. (Italy),
  • LifeSpan BioSciences, Inc. (U.S.),
  • Demeditec Diagnostics GmbH (Germany)

Global Active B12 Test Market - Regional Analysis

According to a report published by Alzheimer's Disease International (ADI), in 2015, around 46.8 million people globally have dementia and it is projected to be around 74.7 million in 2030 and 131.5 million in 2050. Also, according to a report published by WHO in 2017, around 50 million people are suffering from epilepsy globally.
The market of active B12 test is much higher in the Americas region. There are several factors for the tremendous growth of the active B12 test market in this region such as wider acceptance of the technology, Major players belong from this region. According to a report published by Alzheimer's Disease International (ADI), in 2015, around 4.8 million are suffering from dementia in North Americas.

Europe is also considered a huge market for active B12 test players, owing to the present of the huge patient population. Moreover, countries in this region have a well-established health care structure. The population within the reason are more aware of healthcare in comparison to another region like the Asia Pacific and The Middle East and Africa.

Browse Full Report @ https://www.marketresearchfuture.com/reports/active-b12-test-market-4199

The Asia Pacific and the Middle East and Africa region are considering the big opportunity for the market players owing to the presence of a huge patient population. Whereas country like India and china of the Asia Pacific region are considering the fastest-growing region. These countries are open to adopting new technology, and the best treatment option from developed countries in order to improve the quality of life for their public. In 2014, Japanese Pharmaceutical R&D expenditure was around ¥ 14.95 Billion. Japan is a well-developed country and has a well-established healthcare system and technology, whereas developing countries are still focusing on new drugs and technology which lead to an increase in the demand for various active B12 tests in the drug development and delivery process for the treatment.

 About Market Research Future: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end-users, and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. To stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Digital Genome Market Share 2020, Size, top companies, status 2027

-
  The research study presented here is an intelligent take on the Digital Genome Market Share by MRFR that explains important aspects such as competition, segmentation, and regional growth in great detail Digital genome is the study of DNA and other genetic information in plants and animals. It is used to discern the nature of chronic diseases and their ability to cure them in the coming years. The global digital genome market report by Market Research Future (MRFR) takes a look at the challenges and opportunities for the industry for the period of 2018 to 2027 (forecast period). The impact of the COVID-19 pandemic and its effects are explored in great detail. Also Read  https://www.abnewswire.com/pressreleases/digital-genome-market-outlook-2020-key-findings-regional-analysis-covid19-effect-key-players-profiles-future-prospects-and-forecast-to-2027_500552.html Digital Genome Market Scope The global  digital genome market  is expected to accrue major revenue...
Read more

Lymphedema Diagnostics Market Size, Growth Analysis and Technology Enhancements Briefing 2020 To 2023

-
  global lymphedema diagnostics market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 22.6 million in 2018. Lymphatic obstruction or lymphedema is a long-term condition where the excess fluid forms in the body tissue and causes swelling commonly called edema. It develops due to the damaged lymphatic system. Sometimes it also develops after the treatment of breast cancer. Avail a Free sample@ https://www.marketresearchfuture.com/sample_request/8761 Segmentation The global lymphedema diagnostics market has been segmented based on type, technology, disease type, and end user. The market, based on type, has been divided into primary and secondary. The secondary lymphedema is likely to hold maximum market share in the global lymphedema diagnostics market owing to the large population related to the secondary lymphedema presence across the globe. The global lymphedema diagnostics market based on technology has been segregated int...
Read more

Parry-Romberg Syndrome Market 2019 size, share, Analysis, Growth, Guidelines, Overview, Upcoming Trends and Forecast to 2023

-
Image
According to the National Organization for Rare Disorder, Parry-Romberg syndrome is a rare and acquired disorder, which slowly shrink the skin and tissues of half of the face in most of the cases. In rare cases, both sides of the face are affected. In some cases, it may also affect the limbs usually on the same side of the body. The global Parry-Romberg syndrome market is expected grow at a steady CAGR of 7.8% during the forecasted period. The global Parry-Romberg syndrome market is majorly driven by the increasing skin diseases patient population, increasing prevalence neurological disorders, and rapidly increasing demand for better diagnosis & treatment methods. Key players of the market: ·          DePuy Synthes (U.S.) ·          Johnson & Johnson Services, Inc. (US) ·          Medtronic (Ireland, ·     ...
Read more